Organization
University of Zurich / ETH Zurich
9 abstracts
Abstract
Response to neoadjuvant chemotherapy according to molecular subtypes in muscle-invasive bladder carcinoma.Org: University Hospital La Paz - IdiPAZ, Madrid, Spain, Jiménez Díaz Foundation University Hospital, University of Zurich / ETH Zurich, Zurich, Switzerland, IdiPAZ Biobank,
Abstract
Loss of heterozygosity (LOH) in KEAP1/STK11-mutated lung adenocarcinoma to characterize a new subgroup of hard-to-treat patients with unmet need in the real-world setting.Org: Department of Medical Oncology and Hematology, University Hospital Zurich, Department of Pathology and Molecular Pathology, University of Zurich / ETH Zurich,
Abstract
Updated results of the INTELLANCE 2/EORTC trial 1410 randomized phase II study on Depatux –M alone, Depatux-M in combination with temozolomide (TMZ) and either TMZ or lomustine (LOM) in recurrent EGFR amplified glioblastoma (NCT02343406).Org: Erasmus MC Cancer Center, Rotterdam, Netherlands Cancer Institute, Erasmus MC Cancer Institute, University Medical Center, Department of Hematology, Rotterdam, Netherlands, Fondazione IRCCS Istituto Neurologico Carlo Besta,
Abstract
A multi-targeted T-cell engagement of PD1-resistant colorectal cancer cells via delivery of glycopeptide conjugates.Org: Gnubiotics Sciences SA, University Hospital Zurich, University of Zurich / ETH Zurich,
Abstract
EGFR expression and relapse in patients with melanoma receiving adjuvant PD-1-based immunotherapy.Org: Skin Cancer Center, University Hospital Leipzig, Department of Dermatology, Eberhard Karls University of Tuebingen, Tübingen, Germany, Kantonsspital St. Gallen,
Abstract
ABUNDANCE AND ACTIVATION OF MEMORY B-CELLS CHARACTERIZE SYNOVITIS IN RHEUMATOID ARTHRITIS PATIENTS WITH EARLY TREATMENT RESPONSEOrg: University Hospital Zurich, University of Zurich / ETH Zurich, Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, Department of Rheumatology, William Harvey Research Institute, Experimental Medicine and Rheumatology, London, United Kingdom,
Abstract
ALTERED MACROPHAGE POLARIZATION PHENOTYPES IN SYSTEMIC SCLEROSISOrg: University Hospital Zurich, University of Zurich / ETH Zurich, Department of Rheumatology, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Düsseldorf, Germany, Center of Experimental Rheumatology, University Hospital, Immunology, Children's Hospital, Zurich, Switzerland, Zurich, Switzerland,
Abstract
ACTIVATED NEUTROPHILS DEGRADE CARTILAGE ENDPLATESOrg: University of Zurich / ETH Zurich, University Hospital Zurich, University of California San Francisco,
Abstract
ASSOCIATION OF A LOWER BODY-MASS INDEX WITH THE PRESENCE OF ILD IN SSc PATIENTS – A DERIVATION PREDICTION STUDY USING DECISION TREE-BASED ALGORITHMSOrg: University Hospital Zurich, University of Zurich / ETH Zurich, Department of Rheumatology, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Düsseldorf, Germany, Zurich, Switzerland, University of Florence, AOUC,